Lv11
60 积分 2024-10-16 加入
Discovery of ERD-12310A as an Exceptionally Potent and Orally Efficacious PROTAC Degraders of Estrogen Receptor α (ERα)
4小时前
已完结
The polypharmacy combination of the BCL-2 inhibitor venetoclax (VEN) and the FLT3 inhibitor gilteritinib (GIL) is more active in acute myeloid leukemia cells than novel polypharmacologic BCL-2/FLT3 VEN–GIL hybrid single-molecule inhibitors
2个月前
已完结
The polypharmacy combination of the BCL-2 inhibitor venetoclax (VEN) and the FLT3 inhibitor gilteritinib (GIL) is more active in acute myeloid leukemia cells than novel polypharmacologic BCL-2/FLT3 VEN–GIL hybrid single-molecule inhibitors
2个月前
已完结
[Testing for blood alcohol level within the scope of social medicine expert assessment]
3个月前
已关闭
Conformational Constrained 4-(1-Sulfonyl-3-indol)yl-2-phenylaminopyrimidine Derivatives as New Fourth-Generation Epidermal Growth Factor Receptor Inhibitors Targeting T790M/C797S Mutations
4个月前
已完结
Electrochemical oxidation of phenols in flow: a versatile and scalable access topara-benzoquinones
4个月前
已完结
MOF-derived cobalt nanoparticles catalyze a general synthesis of amines
6个月前
已完结
皖公网安备34019202002308
